169
Views
5
CrossRef citations to date
0
Altmetric
Psoriasis

The value of monitoring ciclosporin concentration 2 hours post-dose (C2) in dermatology: A prospective cohort study

, , , &
Pages 79-85 | Received 01 Oct 2009, Accepted 16 Dec 2009, Published online: 01 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sunil Dogra, Rahul Mahajan, Tarun Narang & Sanjeev Handa. (2017) Systemic cyclosporine treatment in severe childhood psoriasis: A retrospective chart review. Journal of Dermatological Treatment 28:1, pages 18-20.
Read now

Articles from other publishers (4)

Cinzia Buligan, Caterina Pinzani, Rossella Cimarosti, Giuseppe Stinco & Massimo Baraldo. (2020) Comparison of clinical effects, trough and peak levels between branded and generic formulation of Cyclosporine in stable psoriatic patients. Giornale Italiano di Dermatologia e Venereologia 155:4.
Crossref
J. Berth‐Jones, L.S. Exton, E. Ladoyanni, M.F. Mohd Mustapa, V.M. Tebbs, P.D. Yesudian, N.J. Levell, P.M. McHenry, T.A. Leslie, S. Wakelin, R.Y.P. Hunasehally, M. Cork, G.A. Johnston, N. Chiang, F.S. Worsnop, A. Salim, D. Buckley, G. Petrof, N. Callachand, T. Flavell & A.A. Salad. (2019) British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018. British Journal of Dermatology 180:6, pages 1312-1338.
Crossref
M. Herrero‐Moyano, J. Pedraz, E. Muñoz‐Aceituno, P. Chicharro, A. Reolid, S. Lara & E. Daudén. (2019) Trough (C0) and 2‐hour postdose (C2) cyclosporine monitoring in patients with moderate‐to‐severe psoriasis. Journal of the European Academy of Dermatology and Venereology 33:5, pages e215-e217.
Crossref
Marcin Marzejon, Monika Kosowska, Daria Majchrowicz, Barbara Bułło-Piontecka, Michał Wąsowicz & Małgorzata Jędrzejewska-Szczerska. (2018) Optical-Spectrometry-Based Method for Immunosuppressant Medicine Level Detection in Aqueous Solutions. Sensors 18:7, pages 2001.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.